tiprankstipranks
Trending News
More News >
Beam Therapeutics (BEAM)
NASDAQ:BEAM
US Market

Beam Therapeutics (BEAM) Income Statement

Compare
2,086 Followers

Beam Therapeutics Income Statement

Last quarter (Q3 2025), Beam Therapeutics's total revenue was $9.70M, a decrease of -32.03% from the same quarter last year. In Q3, Beam Therapeutics's net income was $-112.73M. See Beam Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 63.52M$ 377.71M$ 60.92M$ 51.84M$ 24.00K
Gross Profit
$ -304.04M$ 377.71M$ -250.67M$ -180.29M$ -103.16M
Operating Expenses
$ 111.53M$ 554.19M$ 87.81M$ 212.18M$ 29.60M
Depreciation and Amortization
$ 21.93M$ 29.53M$ 14.15M$ 7.45M$ 4.73M
EBITDA
$ -393.64M$ -146.95M$ -324.33M$ -230.06M$ -128.03M
Operating Income
$ -415.57M$ -176.49M$ -338.48M$ -392.46M$ -132.76M
Other Income/Expenses
$ 38.87M$ 45.32M$ 52.80M$ 21.83M$ -61.83M
Pretax Income
$ -376.70M$ -131.16M$ -285.68M$ -370.64M$ -194.59M
Net Income
$ -376.74M$ -132.53M$ -289.09M$ -370.64M$ -194.59M
Per Share Metrics
Basic EPS
$ -4.58$ -1.72$ -4.13$ -5.77$ -5.49
Diluted EPS
$ -4.58$ -1.72$ -4.13$ -5.77$ -5.49
Weighted Average Shares Outstanding
82.31M 77.15M 70.02M 64.23M 46.73M
Weighted Average Shares Outstanding (Diluted)
82.31M 77.15M 70.02M 64.23M 46.73M
Currency in USD

Beam Therapeutics Earnings and Revenue History